Greenwich LifeSciences, Inc. (GLSI) is a publicly traded Healthcare sector company. As of November 17, 2026, GLSI trades at $13.68 with a market cap of $219.29M and a P/E ratio of -12.06. GLSI moved -0.58% today. Year to date, GLSI is -29.35%; over the trailing twelve months it is +65.34%. Its 52-week range spans $7.78 to $34.10. Rallies surfaces GLSI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for GLSI, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $13.68 |
| Market Cap | $219.29M |
| P/E Ratio | -12.06 |
| EPS | $-1.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $34.10 |
| 52-Week Low | $7.78 |
| Volume | 517 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-19.36M |
| Gross Margin | 0.00% |
GLSI analyst coverage data. Average price target: $0.00.